Rejuvenon Corp.
This article was originally published in Start Up
Executive Summary
Roy Smith, a pre-eminent researcher on the growth hormone pathway, has identified a receptor on the human growth hormone/insulin-like growth factor axis that is an upstream regulator of growth hormones. Rejuvenon Corp. hopes to develop small-molecule activators of this receptor to treat the diseases of aging.